|
|
 |
1st October 2022
New drug slows progression of Alzheimer's
A breakthrough in treating Alzheimer's disease is reported by pharmaceutical companies Eisai and Biogen, using a new drug called lecanemab, which is designed to remove beta-amyloid proteins from the brain.
Read more... |
|
|
 |
18th August 2022
20 exaFLOP supercomputer proposed for 2025
The U.S. Department of Energy (DOE) has published a request for information from computer hardware and software vendors to assist in the planning, design, and commission of next-generation supercomputing systems.
Read more... |
|
|
 |
17th August 2022
Scientists plan "de-extinction" of Tasmanian tiger
The last known thylacine, also called the Tasmanian tiger, died at Australia's Hobart Zoo in 1936. Now, a team of scientists believe they can resurrect the extinct species within 10 years, using stem cells and gene editing technology.
Read more... |
|
|
 |
14th August 2022
Bioengineered cornea restores vision
A bioengineered cornea made from pig's skin is shown to restore vision to blind people. It can be mass produced and stored for up to two years, unlike donated human corneas that are scarce and must be used within two weeks.
Read more... |
|
|
 |
8th August 2022
Progress towards a pan-coronavirus vaccine
Researchers have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer protection against new variants, as well as common colds.
Read more... |
|
|
